[
  {
    "vignette_index": 100,
    "input": "Viral or bacterial conjunctivitis END",
    "output": "THINKING: Use systematic clinical reasoning to develop your treatment approach:  STEP 1 - DIAGNOSIS CONFIRMATION & SEVERITY ASSESSMENT: - Primary diagnosis confidence: Moderate certainty; the presentation of eye redness, swelling, tearing post-soccer suggests acute conjunctivitis, but the final diagnosis of herpetic geniculate ganglionitis indicates possible involvement of herpes zoster ophthalmicus. - Severity classification: Moderate; symptoms are recent (2 days), significant enough to cause discomfort but no mention of vision loss or corneal ulceration. - Urgency level: Urgent care needed due to potential herpetic etiology, which can cause sight-threatening complications if untreated. - Differential considerations still requiring monitoring: Herpetic keratitis, bacterial conjunctivitis, other viral causes like adenovirus.  STEP 2 - EVIDENCE-BASED TREATMENT SELECTION: - First-line treatment per guidelines: Initiate antiviral therapy targeting herpes zoster ophthalmicus if confirmed or strongly suspected. - Supporting evidence: Antiviral therapy (e.g., acyclovir, valacyclovir) reduces severity and duration of herpes zoster ocular complications. - Patient-specific considerations: Anxiety may impact adherence; recent sports activity suggests need for pain management. - Contraindications or cautions: Renal impairment affecting dose adjustment of antivirals.  STEP 3 - PHARMACOLOGICAL INTERVENTIONS: - Primary medication choice: Valacyclovir 1 g orally three times daily for 7-10 days. - Rationale for selection: Higher bioavailability and ease of dosing compared to acyclovir, effective for herpes zoster. - Expected timeline for improvement: Pain and redness should improve within 3-7 days with antiviral treatment. - Key side effects to monitor: Gastrointestinal upset, headache, renal function in high-risk patients. - Alternative medications if first-line fails: Famciclovir or acyclovir.  STEP 4 - NON-PHARMACOLOGICAL INTERVENTIONS: - Primary non-drug interventions: Keep the eye clean, avoid touching or rubbing; use cold compresses for comfort. - Patient education priorities: Importance of completing antiviral course, recognition of worsening symptoms. - Lifestyle modifications: Rest, adequate hydration, stress management. - Behavioral interventions: Anxiety management techniques, reassurance about treatment efficacy.  STEP 5 - MONITORING & FOLLOW-UP STRATEGY: - Follow-up timeline: Reassess in 3-5 days to evaluate response; urgent follow-up if worsening symptoms or vision changes. - Monitoring parameters: Symptom resolution, vision changes, development of corneal involvement. - Red flag symptoms: Increased pain, vision loss, new neurological symptoms. - Treatment response assessment: Reduction in redness, swelling, tearing, and pain.  STEP 6 - PATIENT COMMUNICATION STRATEGY: - Communication approach: Calm, clear explanations emphasizing the seriousness of herpes zoster and the effectiveness of treatment, addressing anxiety openly. - Addressing patient concerns: Reassure about outcomes, clarify treatment steps, and answer questions. - Adherence strategies: Simplify medication schedule, provide written instructions, set expectations. - Family involvement: Involve family if appropriate for support, especially considering patient's anxious nature.  STEP 7 - COORDINATION & REFERRALS: - Specialist referrals needed: Ophthalmologist consultation within 24-48 hours to evaluate ocular involvement. - Other healthcare team members: Primary care follow-up, possibly mental health support for anxiety. - Community resources: Patient education materials on herpes zoster, support groups. - Insurance/cost considerations: Ensure coverage for antivirals and specialist visits.\nANSWER: Based on the diagnosis of viral or bacterial conjunctivitis, with strong suspicion of herpetic etiology, I recommend a comprehensive treatment approach that combines evidence-based antiviral therapy with supportive care, patient education, and close follow-up. The initial management involves starting antiviral medication\u2014valacyclovir 1 g orally three times daily for 7-10 days\u2014and providing symptomatic relief with cold compresses and reassurance. Prompt referral to an ophthalmologist is essential within 24-48 hours for ocular assessment and management. The plan emphasizes monitoring symptom progression, educating the patient about medication adherence and warning signs, and addressing anxiety through clear communication and reassurance. Follow-up will be scheduled within a few days to evaluate response and adjust treatment as necessary, aiming to prevent complications and promote recovery while minimizing risks.",
    "gold_diagnosis": "Acute herpetic geniculate ganglionitis"
  }
]